Welcome to our dedicated page for Prenetics Global SEC filings (Ticker: PRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Prenetics Global's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Prenetics Global's regulatory disclosures and financial reporting.
Prenetics Global Limited reported that its Chief Executive Officer and co‑founder, Danny Sheng Wu Yeung, bought additional shares of the company in the open market. On November 19, 2025, he purchased 20,000 Class A Ordinary Shares at $13.00 per share, for a total purchase price of $260,000. Following this transaction, his total holdings of Class A Ordinary Shares increased to 96,412 shares. This reflects a personal capital commitment by the CEO using his own funds rather than an issuance of new shares by the company.
Prenetics Global Limited (PRE) reported that its Chief Executive Officer and co-founder, Danny Sheng Wu Yeung, bought additional company stock on the open market. On November 18, 2025, he purchased 20,118 Class A Ordinary Shares at a price of $12.02 per share, for a total of about $242,000. Following this transaction, his holdings in the company’s Class A Ordinary Shares increased to 76,412, signaling a higher personal stake in Prenetics’ future performance.
Prenetics Global Limited reported that its Chief Marketing Officer, Rahul Ramchand, bought 30,000 Class A ordinary shares on the open market on November 14, 2025. He paid $13.29 per share, for a total purchase price of $398,821. Following this transaction, his total holdings increased to 75,553 Class A ordinary shares of the company. This filing simply records the executive share purchase and resulting ownership level.
Prenetics Global Limited reported that its Chief Marketing Officer, Rahul Ramchand, purchased 30,000 Class A Ordinary Shares in the open market on November 12, 2025 at $13.17 per share, for a total of $395,151. Following this transaction, his holdings increased to 45,553 Class A Ordinary Shares.
The purchase was disclosed via a Form 6-K and reflects an executive open-market buy.
Prenetics Global Limited filed a Form 6‑K furnishing a press release with its unaudited financial results for the third quarter ended September 30, 2025. The filing states that this report is incorporated by reference into the company’s existing Form F‑3 and Form S‑8 registration statements. The press release is attached as Exhibit 99.1.
Prenetics Global Limited closed a best efforts public offering of 2,722,642 Class A ordinary shares, each sold together with one Class A warrant and one Class B warrant at a combined price of $16.08 per unit. The company reported gross proceeds of approximately $44 million.
The Class A and Class B warrants are immediately exercisable for up to 2,722,642 shares each at exercise prices of $24.12 and $32.16, respectively, and have a five-year term from closing. Dominari Securities LLC acted as sole placement agent; compensation was an 8% cash success fee (reduced to 4% for company-introduced investors). Prenetics also issued placement agent warrants to purchase 131,829 shares at $16.08.
Prenetics plans to use proceeds for global expansion of IM8, development and implementation of its Bitcoin treasury strategy, working capital, and general corporate purposes. The transaction was conducted under an effective Form F-3 and closed on October 28, 2025.
Prenetics Global Limited launched a primary offering of 2,722,642 Class A Ordinary Shares at $16.08 per share sold together with one Class A warrant and one Class B warrant, plus warrants to purchase up to 5,445,284 shares and Placement Agent Warrants to purchase up to 131,829 shares. Gross proceeds are $43,779,297.56 with estimated net proceeds of $40.1 million.
Each Class A warrant is exercisable at $24.12 and each Class B warrant at $32.16, both immediately exercisable and expiring five years from issuance; the warrants will not be listed and may have limited liquidity. Dominari Securities LLC acted as exclusive placement agent with fees of 8% (reduced to 4% for certain investors) and warrant coverage. Shares outstanding were 12,524,823 Class A and 1,580,972 Class B prior to the offering and will be 15,247,465 Class A and 1,580,972 Class B immediately after.
The Company intends to use proceeds to expand IM8 globally, develop and implement its Bitcoin treasury strategy, and for working capital and general corporate purposes. The filing highlights risks including immediate dilution, lack of a trading market for the warrants, PFIC considerations, and Bitcoin-related volatility and custody risks.
Prenetics Global Limited furnished a Form 6-K noting it issued a press release announcing the pricing and subscription of its best efforts public offering. The press release is included as Exhibit 99.1. The report is signed by Chief Financial Officer Lo Hoi Chun on October 27, 2025.
Prenetics Global Limited submitted a Form 6-K as a foreign private issuer to provide an update for October 2025. The company states that on October 27, 2025 it issued a press release announcing the pricing of its best efforts public offering. The press release describing this offering is included with the report as Exhibit 99.1.
Prenetics Global Limited launched a preliminary prospectus supplement for a primary offering of Class A Ordinary Shares and/or Pre-funded Warrants, each sold together with one Class A Warrant and one Class B Warrant. The Class A and Class B Warrants are exercisable immediately and will expire five years from issuance. The warrants and Pre-funded Warrants will be issued separately but are not being listed, so liquidity may be limited.
Dominari Securities LLC is engaged as exclusive placement agent on a reasonable best efforts basis, with cash fees of 8% of gross proceeds (reduced to 4% for company-introduced investors) and placement agent warrants equal to up to 6% of the securities sold (reduced to 2% for directed orders). Pre-funded Warrants are available to investors whose share purchases would otherwise exceed 4.99% (or, at the purchaser’s election, 9.99%) beneficial ownership. Net proceeds are intended for IM8 global expansion, development and implementation of the Company’s Bitcoin treasury strategy, working capital and general corporate purposes.